Phenylalanine Fibrils Seed Native Lysozyme to Form Membrane-Active Pathological Complexes at Physiological Conditions
The Journal of Physical Chemistry B · 29.10.2026 · 130 (43) · 11361-11368
DOI: 10.1021/acs.jpcb.6c03957 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Physical Chemistry B, online erschienen am 14.10.2026. Verfasst von Sourav Nandi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biological Sciences, S. N. Bose National Centre for Basic Sciences, JD-Block, Sector-III, Salt Lake, Kolkata700106, India. Hauptthemen laut MEDLINE: Muramidase, Phenylalanine, Amyloid. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Science and Engineering Research Board.
Abstract (Originalsprache)
Accumulation of metabolites at pathological concentrations can trigger nonclassical protein aggregation pathways that remain poorly understood. Here, we explore the molecular mechanism by which the metabolite phenylalanine (Phe), known to form amyloid-like fibrils in Phenylketonuria disease, induces a globular protein to form complex structures. We demonstrate that Phe fibrils act as molecular scaffolds to promote aggregation of a stable globular protein lysozyme (Lyz) under physiological conditions (pH 7.4, 37 °C), resulting in the formation of a heteronuclear Lyz–Phe complex. Spectroscopic and biophysical analyses reveal that π–π interactions between Trp residues of Lyz and the aromatic surface of Phe fibrils drive the initial association; additional hydrophobic interactions stabilize the complex. Unlike classical amyloidogenesis dominated by β-sheet enrichment in proteins, this heteronuclear complexation induces a substantial increment of random coil content in the protein’s secondary structure with only a modest increase in the β-sheet content. The resulting complex strongly interacts with phospholipid bilayer membranes, compromises the membrane integrity, and exhibits significant cytotoxicity toward cultured mammalian fibroblast cells (L929). This study offers a hitherto unexplored alternative aggregation mechanism in which a metabolite imbalance, rather than intrinsic protein instability, converts a native globular protein into membrane-active, cytotoxic assemblies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biological Sciences, S. N. Bose National Centre for Basic Sciences, JD-Block, Sector-III, Salt Lake, Kolkata700106, India.
- Centre for Healthcare Science and Technology, Indian Institute of Engineering Science and Technology, Shibpur, Howrah711103, West Bengal, India.
ORCID-Profile: Sourav Nandi, Ananya Barui, Rajib Kumar Mitra
Förderung
- Science and Engineering Research Board
Zitieren
APA
Nandi, S., Mukherjee, S., Mondal, D., Barui, A., & Mitra, R. K. (2026). Phenylalanine Fibrils Seed Native Lysozyme to Form Membrane-Active Pathological Complexes at Physiological Conditions. The Journal of Physical Chemistry B, 130(43), 11361-11368. https://doi.org/10.1021/acs.jpcb.6c03957
Vancouver
Nandi S, Mukherjee S, Mondal D, Barui A, Mitra RK. Phenylalanine Fibrils Seed Native Lysozyme to Form Membrane-Active Pathological Complexes at Physiological Conditions. The Journal of Physical Chemistry B. 2026;130(43):11361-11368. doi:10.1021/acs.jpcb.6c03957
BibTeX
@article{Nandi2026,
author = {Nandi, Sourav and Mukherjee, Shrabasti and Mondal, Dipu and Barui, Ananya and Mitra, Rajib Kumar},
title = {Phenylalanine Fibrils Seed Native Lysozyme to Form Membrane-Active Pathological Complexes at Physiological Conditions},
journal = {The Journal of Physical Chemistry B},
year = {2026},
volume = {130},
number = {43},
pages = {11361--11368},
doi = {10.1021/acs.jpcb.6c03957}
}
EUVIMED